Benzimidazole derivatives as modulators of IgE
US6919366B2 · kind B2 · utility
29Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2001 |
| Grant date | Jul 19, 2005 |
| Priority date | — |
| Expiry date | Apr 18, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a family of benzimidazole analogs, which are inhibitors of the IgE response to allergens. These compounds are useful in the treatment of allergy, asthma, or any diseases where IgE is pathogenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.